摘要
目的系统评价维生素D治疗多囊卵巢综合征(PCOS)的有效性。方法计算机检索PubMed、EMbase、The Cochrane Library、Web of Science、EBSCO、CBM、WanFang Data、CNKI和VIP数据库,搜集有关维生素D治疗PCOS的随机对照试验(RCT),检索时限均为建库至2019年7月。由2名研究者独立筛选文献、提取资料并评价纳入研究的偏倚风险后,采用RevMan 5.3软件进行Meta分析。结果共纳入11个RCT,包括692例患者。Meta分析结果显示:与安慰剂相比,维生素D能降低超敏C反应蛋白(hs-CRP)[MD=-0.54,95%CI(-1.00,-0.08),P=0.02]和总睾酮[MD=-0.17,95%CI(-0.29,-0.05),P=0.004]水平,增加子宫内膜厚度[MD=1.78,95%CI(0.49,3.06),P=0.007]。但两组在性激素结合球蛋白(SHBG)水平、多毛症评分(mF-G)变化方面的差异均无统计学意义(P>0.05)。结论当前证据表明,补充维生素D能显著降低PCOS的总睾酮和hs-CRP水平,增加子宫内膜厚度。受纳入研究数量和质量的限制,上述结论尚待更多高质量研究予以验证。
Objective To systematically review the efficacy of vitamin D supplementation on patients with polycystic ovary syndrome(PCOS).Methods PubMed,EMbase,The Cochrane Library,Web of Science,EBSCO,CBM,WanFang Data,CNKI and VIP databases were electronically searched to collect randomized controlled trials(RCTs)on the efficacy of vitamin D supplementation for PCOS from inception to July 2019.Two reviewers independently screened literature,extracted data and assessed risk of bias of included studies,then,meta-analysis was performed by using RevMan5.3 software.Results A total of 11 RCTs involving 692 patients were included.The results of meta-analysis showed that compared with placebo,vitamin D could reduce the level of hypersensitive C-reactive protein(hs-CRP)(MD=-0.54,95%CI-1.00 to-0.08,P=0.02)and total testosterone(MD=-0.17,95%CI-0.29 to-0.05,P=0.004),and increase endometrial thickness(MD=1.78,95%CI 0.49 to 3.06,P=0.007).However,there were no significant differences between two groups in the incidence of sex hormone binding globulin(SHBG)level and hypertrichosis’s score(mF-G)(P>0.05).Conclusions Current evidence indicates that vitamin D supplementation can significantly reduce the level of total testosterone and hs-CRP,and increase endometrial thickness of PCOS.Due to the limited quality and quantity of the included studies,more high quality studies are required to verify the above conclusions.
作者
柳雨雨
袁涛
李海鸿
仇杰
邱文文
虎亚光
杨克虎
LIU Yuyu;YUAN Tao;LI Haihong;QIU Jie;QIU Wenwen;HU Yaguang;YANG Kehu(School of Nursing,Gansu University of Chinese Medicine,Lanzhou 730000,P.R.Chitia;Gansu Provincial Maternity and Childcare Hospital,Lanzhou 730050,P.R.China;Department of Pain Medicine,The First Hospital of Lanzhou University,Lanzhou 730000,P.R.China;Evidence-based Medicine Center of Lanzhou University,Lanzhou 730000,P.R.China;Key Laboratory of Evidence-based Medicine and Clinical Transformation in Gansu Province,Lanzhou 730000,P.R.China)
出处
《中国循证医学杂志》
CSCD
北大核心
2020年第6期695-701,共7页
Chinese Journal of Evidence-based Medicine
基金
中央高校基本科研业务费专项资金(编号:lzujbky-2019-ct02)。